FTSE 100 Rises as Miners Benefit from Stronger Gold Prices

FTSE Futures

Britain’s FTSE 100 experienced an uptick on Monday, driven by a decline in oil prices that alleviated concerns regarding inflation, alongside an increase in gold prices that buoyed the shares of precious metal mining companies. Meanwhile, investors were evaluating the most recent jobs report from the UK.

The blue-chip FTSE 100 index rose 0.6% to 10,746.09 points by 1054, while the midcap FTSE 250 slipped 0.4%.

  • Precious metal miners experienced a rise of 3.4%, correlating with the increase in gold prices. Notable contributors to this upward trend include Endeavour Mining, Antofagasta, and Anglo American, all of which ranked among the benchmark index’s top gainers.
  • Gold prices increased by 0.7% as declining oil prices alleviated inflation worries. Meanwhile, investors are anticipating US inflation data set to be released later this week, which may influence projections regarding the Federal Reserve’s interest rate trajectory.
  • Gold is often regarded as a safeguard against inflation; however, elevated interest rates generally diminish the attractiveness of non-yielding bullion.
  • Oil prices declined by over 1%, impacting energy stocks, following US President Donald Trump’s assertion that renewed strikes on Iran were improbable. However, ongoing attacks on vessels near the Strait of Hormuz continued to raise supply concerns.
  • The household goods index was the worst-performing sector, falling 1.1% as homebuilders Persimmon and Barratt Redrow lost about 1.5% each.
  • In October, the data indicated a cooling in Britain’s jobs market; however, a survey of recruiters released on Monday revealed that starting salaries for permanent positions increased at an accelerated rate.
  • The BoE raised interest rates by a quarter-point to 4% last week, with policymakers cautioning that at least one more increase was likely if the US-Iran conflict persisted. Market participants anticipate a minimum of two 25 basis-point increases in 2027, as indicated by LSEG data.
  • Among individual stocks, GSK rose 1% after the British drugmaker announced on Friday that it had settled patent litigation with Moderna related to COVID-19 vaccines Spikevax and mNEXSPIKE, as well as the RSV vaccine mResvia, thereby concluding lawsuits that claimed the shots infringed GSK’s patents.